R L McNamara1, J A Lima, P K Whelton, N R Powe. 1. Johns Hopkins Medical Institutions, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland, USA.
Abstract
BACKGROUND: No consensus exists about the use of imaging strategies to identify potential cardiovascular sources of emboli in patients who have had strokes. OBJECTIVE: To determine the cost-effectiveness of various cardiac imaging strategies after stroke. DESIGN: A markov model decision analysis was used to evaluate the benefits and costs of nine diagnostic strategies, including transthoracic echocardiography, transesophageal echocardiography, sequential approaches, selective imaging, and no imaging. SETTING: Simulated clinical practice in the United States. PATIENTS: Hypothetical patients with a first stroke who were in normal sinus rhythm. MEASUREMENTS: Echocardiographic detection rates of potential sources of emboli were ascertained by doing a systematic review of the literature. Values for event rates, anticoagulation effects, utilities, and costs were obtained from the literature and Medicare data. RESULTS: When visualized left atrial thrombus was used as the only indication for anticoagulation, transesophageal echocardiography performed only in patients with a history of cardiac problems cost $9000 per quality-adjusted life-year; transesophageal echocardiography in all patients cost $13,000 per quality-adjusted life-year. Cost savings and decreased morbidity and mortality rates associated with reduction in preventable recurrent strokes substantially offset examination costs and risks of anticoagulation. These results were moderately sensitive to efficacy of anticoagulation and incidence of intracranial bleeding during anticoagulation and were mildly sensitive to prevalence of left atrial thrombus, rate of recurrent stroke in patients with thrombus, quality of life after stroke, cost of transesophageal echocardiography, and specificity of transesophageal echocardiography. Transthoracic echocardiography, alone or in sequence with transesophageal echocardiography, was not cost-effective compared with transesophageal echocardiography. CONCLUSION: Physicians should consider doing transesophageal echocardiography in all patients with new-onset stroke.
BACKGROUND: No consensus exists about the use of imaging strategies to identify potential cardiovascular sources of emboli in patients who have had strokes. OBJECTIVE: To determine the cost-effectiveness of various cardiac imaging strategies after stroke. DESIGN: A markov model decision analysis was used to evaluate the benefits and costs of nine diagnostic strategies, including transthoracic echocardiography, transesophageal echocardiography, sequential approaches, selective imaging, and no imaging. SETTING: Simulated clinical practice in the United States. PATIENTS: Hypothetical patients with a first stroke who were in normal sinus rhythm. MEASUREMENTS: Echocardiographic detection rates of potential sources of emboli were ascertained by doing a systematic review of the literature. Values for event rates, anticoagulation effects, utilities, and costs were obtained from the literature and Medicare data. RESULTS: When visualized left atrial thrombus was used as the only indication for anticoagulation, transesophageal echocardiography performed only in patients with a history of cardiac problems cost $9000 per quality-adjusted life-year; transesophageal echocardiography in all patients cost $13,000 per quality-adjusted life-year. Cost savings and decreased morbidity and mortality rates associated with reduction in preventable recurrent strokes substantially offset examination costs and risks of anticoagulation. These results were moderately sensitive to efficacy of anticoagulation and incidence of intracranial bleeding during anticoagulation and were mildly sensitive to prevalence of left atrial thrombus, rate of recurrent stroke in patients with thrombus, quality of life after stroke, cost of transesophageal echocardiography, and specificity of transesophageal echocardiography. Transthoracic echocardiography, alone or in sequence with transesophageal echocardiography, was not cost-effective compared with transesophageal echocardiography. CONCLUSION: Physicians should consider doing transesophageal echocardiography in all patients with new-onset stroke.
Authors: Flemming J Olsen; Peter G Jørgensen; Rasmus Møgelvang; Jan S Jensen; Thomas Fritz-Hansen; Jan Bech; Jacob Sivertsen; Tor Biering-Sørensen Journal: Int J Cardiovasc Imaging Date: 2015-07-21 Impact factor: 2.357
Authors: Scott E Kasner; Michael J Lynn; Bryon P Jackson; Patrick M Pullicino; Marc I Chimowitz Journal: J Stroke Cerebrovasc Dis Date: 2007 Sep-Oct Impact factor: 2.136
Authors: Dawn Lee; Patrick Thornton; Alexander Hirst; Lucie Kutikova; Robert Deuson; Nic Brereton Journal: Appl Health Econ Health Policy Date: 2013-10 Impact factor: 2.561